Page 98 - Read Online

Page 8 of 12 Papadodima et al. J Transl Genet Genom 2019;3:7. I https://doi.org/10.20517/jtgg.2018.33

Chatziioannou A

Availability of data and materials
Not applicable.

Financial support and sponsorship
This work was supported by “TRANSITION: TRANSlating the complexIty of melanoma diagnosis into
raTional therapeutic stratificatiON” (MIS 5031295) which is implemented under the Action “Reinforcement
of the Research and Innovation Infrastructure”, funded by the Operational Programme “Competitiveness,
Entrepreneurship and Innovation” (NSRF 2014-2020) and co-financed by Greece and the European Union
(European Regional Development Fund).

Conflicts of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2019.

REFERENCES
1. Uong A, Zon LI. Melanocytes in development and cancer. J Cell Physiol 2010;222:38-41.
2. Nikolaou V, Stratigos A. Emerging trends in the epidemiology of melanoma. Br J Dermatol 2014;170:11-9.
3. Garbe C, Leiter U. Melanoma epidemiology and trends. Clinics in dermatology 2009;27:3-9.
4. ECIS - European Cancer Information System. Available from: https://ecis.jrc.ec.europa.eu [Last accessed on 26 Feb 2019]
5. Forsea AM, Del Marmol V, De Vries E, Bailey E, Geller A. Melanoma incidence and mortality in Europe: new estimates, persistent
disparities. Br J Dermatol 2012;167:1124-30.
6. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PA, Ally DS, et al. Germline p16 mutations in familial melanoma. Nature genetics
1994;8:15-21.
7. Kamb A, Shattuck-Eidens D, Eeles R, Liu Q, Gruis NA, et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p
melanoma susceptibility locus. Nature genetics 1994;8:23-6.
8. de Snoo FA, Hayward NK. Cutaneous melanoma susceptibility and progression genes. Cancer Lett 2005;230:153-86.
9. Aoude LG, Wadt KA, Pritchard AL, Hayward NK. Genetics of familial melanoma: 20 years after CDKN2A. Pigment Cell Melanoma Res
2015;28:148-60.
10. Athanasiadis EI, Antonopoulou K, Chatzinasiou F, Lill CM, Bourdakou MM, et al. A Web-based database of genetic association studies in
cutaneous melanoma enhanced with network-driven data exploration tools. Database (Oxford) 2014;2014:bau101.
11. Antonopoulou K, Stefanaki I, Lill CM, Chatzinasiou F, Kypreou KP, et al. Updated field synopsis and systematic meta-analyses of genetic
association studies in cutaneous melanoma: the MelGene database. J Invest Dermatol 2015;135:1074-9.
12. Chatzinasiou F, Lill CM, Kypreou K, Stefanaki I, Nicolaou V, et al. Comprehensive field synopsis and systematic meta-analyses of genetic
association studies in cutaneous melanoma. J Natl Cancer Inst 2011;103:1227-35.
13. Law MH, Bishop DT, Lee JE, Brossard M, Martin NG, et al. Genome-wide meta-analysis identifies five new susceptibility loci for
cutaneous malignant melanoma. Nature genetics 2015;47:987-95.
14. Padua RA, Barrass N, Currie GA. A novel transforming gene in a human malignant melanoma cell line. Nature 1984;311:671-3.
15. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, et al. Mutations of the BRAF gene in human cancer. Nature 2002;417:949-54.
16. Pleasance ED, Cheetham RK, Stephens PJ, McBride DJ, Humphray SJ, et al. A comprehensive catalogue of somatic mutations from a
human cancer genome. Nature 2010;463:191-6.
17. Hodis E, Watson IR, Kryukov GV, Arold ST, Imielinski M, et al. A landscape of driver mutations in melanoma. Cell 2012;150:251-63.
18. Krauthammer M, Kong Y, Ha BH, Evans P, Bacchiocchi A, et al. Exome sequencing identifies recurrent somatic RAC1 mutations in
melanoma. Nature genetics 2012;44:1006-14.
19. The Cancer Genome Atlas [Internet]. Available from: https://cancergenome.nih.gov/. [Last accessed on 24 Feb 2019]